These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2974352)

  • 1. [Electrocardiographic changes in kidney transplant under immunodepressive therapy with Cy-A].
    Iacovoni P; Fortezza P; Boffo V; Baroni B; Pisani F; Utzeri G; Casciani CU
    Clin Ter; 1988 Mar; 124(6):435-42. PubMed ID: 2974352
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
    Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
    Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients.
    Termeer A; Hoitsma AJ; Koene RA
    Transplantation; 1986 Aug; 42(2):220-1. PubMed ID: 3526659
    [No Abstract]   [Full Text] [Related]  

  • 8. Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity.
    Pallardo LM; Sanchez J; Garcia J; Moreno RF; Rochera A; Cabezuelo J
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):26-7. PubMed ID: 3051582
    [No Abstract]   [Full Text] [Related]  

  • 9. Infiltrate analysis by monoclonal antibodies does not contribute to the usefulness of fine needle aspiration biopsy.
    van Oers MH; Surachno S; Wilmink JM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1646-9. PubMed ID: 3547873
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
    Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal results in cadaveric renal transplantation with low-dose cyclosporine and steroids combined with prophylactic anti-lymphocyte globulin.
    Fries D; Hiesse C; Charpentier B; Cantarovich M; Lantz O; Benoit G
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):23-5. PubMed ID: 3051581
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of low-dose cyclosporine A on histopathologic findings in transplant biopsy specimens and function rates after cadaver renal transplantation.
    Niebel W; Metz K; Donhuijsen D; Albrecht KH; Windeck R; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1772-5. PubMed ID: 3547882
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up.
    Wagner K; Neumayer HH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1353-7. PubMed ID: 3547865
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.